152 related articles for article (PubMed ID: 37221131)
21. Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice.
Amagai M; Nishikawa T; Nousari HC; Anhalt GJ; Hashimoto T
J Clin Invest; 1998 Aug; 102(4):775-82. PubMed ID: 9710446
[TBL] [Abstract][Full Text] [Related]
22. Paraneoplastic pemphigus.
Yong AA; Tey HL
Australas J Dermatol; 2013 Nov; 54(4):241-50. PubMed ID: 22759072
[TBL] [Abstract][Full Text] [Related]
23. Sensitivity and specificity of clinical, histologic, and immunologic features in the diagnosis of paraneoplastic pemphigus.
Joly P; Richard C; Gilbert D; Courville P; Chosidow O; Roujeau JC; Beylot-Barry M; D'incan M; Martel P; Lauret P; Tron F
J Am Acad Dermatol; 2000 Oct; 43(4):619-26. PubMed ID: 11004616
[TBL] [Abstract][Full Text] [Related]
24. Detection and characterization of anti-envoplakin linker autoantibodies in paraneoplastic pemphigus using specific bead-based assay.
Mouquet H; Drenovska K; Lartigue A; Joly P; Drouot L; Thomas M; Tron F; Gilbert D
Clin Immunol; 2008 Nov; 129(2):304-12. PubMed ID: 18790674
[TBL] [Abstract][Full Text] [Related]
25. [Clinical analysis of 30 cases of Castleman disease with different types of thoracic involvement].
Zhang XX; Jiang L; Wang CY; Gu YY; Li LG; Xia TT; Huang Y; Huang PK; Zhang QL
Zhonghua Xue Ye Xue Za Zhi; 2020 Feb; 41(2):149-156. PubMed ID: 32135633
[No Abstract] [Full Text] [Related]
26. Detection of autoantibodies against alpha-2-macroglobulin-like 1 in paraneoplastic pemphigus sera utilizing novel green fluorescent protein-based immunoassays.
Bazzini C; Begré N; Favre B; Hashimoto T; Hertl M; Schlapbach C; Borradori L
J Dermatol Sci; 2020 Jun; 98(3):173-178. PubMed ID: 32439251
[TBL] [Abstract][Full Text] [Related]
27. Is tocilizumab a potential therapeutic option for refractory unicentric Castleman disease?
Abid MB; Peck R; Abid MA; Al-Sakkaf W; Zhang Y; Dunnill GS; Staines K; Sequeiros IM; Lowry L
Hematol Oncol; 2018 Feb; 36(1):320-323. PubMed ID: 28401573
[TBL] [Abstract][Full Text] [Related]
28. [Surgical treatment and prognosis analysis of localized retroperitoneal Castleman disease: a study of 20 cases].
Tang JQ; Yang YM; Xiong Y; Wan YL; Zhu XJ
Zhonghua Wai Ke Za Zhi; 2009 Nov; 47(22):1685-8. PubMed ID: 20137716
[TBL] [Abstract][Full Text] [Related]
29. Paraneoplastic pemphigus associated with follicular dendritic cell sarcoma arising from Castleman's tumor.
Lee IJ; Kim SC; Kim HS; Bang D; Yang WI; Jung WH; Chi HS
J Am Acad Dermatol; 1999 Feb; 40(2 Pt 2):294-7. PubMed ID: 10025851
[TBL] [Abstract][Full Text] [Related]
30. Next-generation sequencing of idiopathic multicentric and unicentric Castleman disease and follicular dendritic cell sarcomas.
Nagy A; Bhaduri A; Shahmarvand N; Shahryari J; Zehnder JL; Warnke RA; Mughal T; Ali S; Ohgami RS
Blood Adv; 2018 Mar; 2(5):481-491. PubMed ID: 29496669
[TBL] [Abstract][Full Text] [Related]
31. Paraneoplastic Pemphigus and Bronchiolitis Obliterans in a Patient with Splenic B-cell Lymphoma.
Wang SH; Chu CY; Chen HH; Chang YL; Chen KY; Chiu HC
J Formos Med Assoc; 2007 Sep; 106(9):768-73. PubMed ID: 17908666
[TBL] [Abstract][Full Text] [Related]
32. Clinical characteristics and prognosis of patients with Castleman disease in a Chinese hospital: paraneoplastic pemphigus is an independent risk factor.
Hua Y; Liang C; Yang J; Wang L; Xu A; Xi L; Wang S; Wang Z
Am J Transl Res; 2022; 14(2):1051-1059. PubMed ID: 35273707
[TBL] [Abstract][Full Text] [Related]
33. Autoantibody production from a thymoma and a follicular dendritic cell sarcoma associated with paraneoplastic pemphigus.
Wang J; Bu DF; Li T; Zheng R; Zhang BX; Chen XX; Zhu XJ
Br J Dermatol; 2005 Sep; 153(3):558-64. PubMed ID: 16120143
[TBL] [Abstract][Full Text] [Related]
34. Bronchiolitis obliterans, Castleman's disease, and a bullous disease: pemphigus vulgaris or paraneoplastic pemphigus?
Pizarro A; García-Tobaruela A; Pinilla J
Hum Pathol; 1998 Jun; 29(6):657-8. PubMed ID: 9635692
[No Abstract] [Full Text] [Related]
35. Detection of anti-envoplakin and anti-periplakin autoantibodies by ELISA in patients with paraneoplastic pemphigus.
Huang Y; Li J; Zhu X
Arch Dermatol Res; 2009 Oct; 301(10):703-9. PubMed ID: 18820940
[TBL] [Abstract][Full Text] [Related]
36. Paraneoplastic pemphigus associated with bronchiolitis obliterans.
Takahashi M; Shimatsu Y; Kazama T; Kimura K; Otsuka T; Hashimoto T
Chest; 2000 Feb; 117(2):603-7. PubMed ID: 10669715
[TBL] [Abstract][Full Text] [Related]
37. Paraneoplastic pemphigus and myasthenia gravis as the first manifestations of a rare case of pancreatic follicular dendritic cell sarcoma: CT findings and review of literature.
Lu T; Song B; Pu H; Li X; Chen Q; Yang C
BMC Gastroenterol; 2019 Jun; 19(1):92. PubMed ID: 31200650
[TBL] [Abstract][Full Text] [Related]
38. [Paraneoplastic pemphigus revealing dendritic cell sarcoma originating from Castleman's disease of the neck].
Gironet N; De Muret A; Machet L; Diot P; Rivollier C; Dumont P; Lorette G; Vaillant L
Ann Dermatol Venereol; 2005 Jan; 132(1):41-4. PubMed ID: 15746607
[TBL] [Abstract][Full Text] [Related]
39. Multidisciplinary diagnosis and treatment of recurrent follicular dendritic cell sarcoma in abdomen: A case report.
Qu C; Tian X; Ma Y; Xie X; Wang M; Dong Y; Zhang J; Liu P; Yang Y
Medicine (Baltimore); 2020 Dec; 99(51):e23588. PubMed ID: 33371089
[TBL] [Abstract][Full Text] [Related]
40. No involvement of IgG autoantibodies against extracellular domains of desmoglein 2 in paraneoplastic pemphigus or inflammatory bowel diseases.
Ota T; Amagai M; Watanabe M; Nishikawa T
J Dermatol Sci; 2003 Aug; 32(2):137-41. PubMed ID: 12850306
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
